Translational cancer research
The Cancer Institute NSW is one of the biggest funders of cancer research in the state with a focus on translational cancer research.
Discover how we are improving our investment in translational cancer research to ensure patients across NSW are provided with world-class care.
Translational cancer research – also termed ‘bench to bedside’ – aims to efficiently translate research findings from the laboratory into clinical practice for rapid impact on cancer treatment and outcomes.
The stages in translational research are designed to ensure that the discoveries that advance into human trials have the highest possible chance of success in terms of both safety and efficacy.
Learn more about how we support translational cancer research and the impact of our research achievements on improving cancer outcomes across the state.